Articles from GoodRx

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is offering free online healthcare provider visits to California residents impacted by the wildfires devastating Los Angeles County. Starting today, Angelenos can use the code LA-GOODRX-CARE to be seen by a licensed medical provider on GoodRx Care for a variety of conditions.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced a new GoodRx for Pets experience that provides a more affordable and convenient way for Americans to access pet medications. Through GoodRx for Pets, pet owners can find savings and have pet medications delivered right to their door. GoodRx for Pets provides a seamless experience for pet owners, combining convenience, affordability, and accessibility in one place.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today revealed startling healthcare disparities in its new report, “Endocrinologist Deserts: A Critical Healthcare Gap for Millions in the U.S.” With nearly 70% of U.S. counties lacking an endocrinologist, the report paints a stark picture of the barriers millions of Americans face in managing life-threatening conditions like diabetes.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today released a new Weight Loss Medications Tracker that provides an inside look at fill trends and spending patterns for weight loss medications across the U.S. The company found that limited insurance coverage and high out-of-pocket costs aren’t slowing down interest in popular drugs used for weight loss such as Mounjaro, Ozempic, Wegovy, and Zepbound. In fact, some of these popular drugs have seen fills more than double in just the past year. What’s more, GoodRx’s research shows that Americans overspent by at least $200 million in 2024 by paying the full retail price for their weight loss medications and not leveraging savings available on GoodRx, showcasing an astounding willingness to access these medications at any cost.

Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with Opill® as its launch partner. This new seamless direct-to-consumer shopping experience allows consumers to order eligible health products and medications on the GoodRx platform and have them shipped directly to their door. Not only does this mark GoodRx’s entry into the over-the-counter (OTC) market, but it offers valuable partnership opportunities for consumer health and pharmaceutical brands looking to leverage GoodRx’s extensive reach and scale.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced today that QSYMIA® (phentermine and topiramate extended-release capsules CIV) is available for a low cash price in more than 70,000 retail pharmacy locations nationwide exclusively via GoodRx. This initiative not only propels GoodRx’s momentum in weight loss solutions, but also broadens its portfolio in offering significant savings on brand-name medications, making obesity treatment more accessible and affordable for millions.

GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced the election of Ronald E. Bruehlman to its Board of Directors, effective November 8, 2024. Mr. Bruehlman brings to GoodRx 39 years of finance experience in the healthcare services, industrial and petroleum industries. He currently serves as Chief Financial Officer of IQVIA, a global provider of advanced analytics, technology solutions, and contract research. Prior to IQVIA, he served as CFO of IMS Health and had a 23-year career at United Technologies Corporation, where he held multiple senior finance leadership roles of increasing responsibility. Mr. Bruehlman previously served on the board of directors of Atotech Ltd., Q-Squared Solutions, and Clipper Windpower.

Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., announced the availability of new affordability programs for menopause hormone therapies by Pfizer. Through the reach and scale of the GoodRx platform, these programs are broadening access and affordability of crucial medications for women.

GoodRx (NASDAQGDRX), the leading prescription savings platform in the U.S., today announced consumers will soon be able to use Affirm to pay over time for select medications at participating retail pharmacies. This adds a convenient way for consumers to pay for their medications directly on the GoodRx platform.

GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced it is working with ARS Pharmaceuticals, Inc. (“ARS Pharmaceuticals”) to offer the lowest discounted cash price for neffy® in retail pharmacy locations. Available for purchase in-store this week, consumers who have been prescribed neffy can now access a pack of two single-use neffy devices for $199 at more than 70,000 pharmacies nationwide exclusively through GoodRx.

Today, GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., debuted its new Prescription Cost Tracker where it will monitor out-of-pocket prescription spending trends in the U.S. to help Americans better understand prescription affordability and price transparency. Helping Americans get the healthcare they need starts with tackling the barriers of costs and coverage, and there are three key factors driving the financial burden for prescriptions: high medication costs, reduced insurance coverage and increased friction. The Prescription Cost Tracker, which will be regularly updated to reflect the latest available data, helps examine these factors and illustrate why 51 million Americans leave prescription medications unfilled every month and many more face high costs at the counter.

GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced the election of Simon Patterson to its Board of Directors. Currently leading EMEA operations for the technology investment firm Silver Lake, Mr. Patterson brings to GoodRx decades of technology, strategy and management experience. Mr. Patterson also serves on the boards of IVC Evidensia, New Zealand Rugby Commercial, RAC, and ZPG, and previously served on the boards of Cegid, Dell Technologies, FlixBus, Gerson Lehrman Group, Intelsat, MultiPlan and Skype.

Today, GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., was named to the fourth-annual TIME100 Most Influential Companies list, which highlights companies making an extraordinary impact around the world. This is the second time GoodRx has received this honor for helping Americans get the medications they need at a price they can afford.

GoodRx, the leading destination for prescription savings in the U.S., today announced it is offering discounts of up to 43% on fertility treatments based on the best available GoodRx price,1 including savings on generic and brand-name medications used during every phase of the in vitro fertilization (IVF) process. These discounts can help manage the high costs that families and individuals face when trying to expand their families.

GoodRx (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced a new direct contracting agreement with The Kroger Co. to deliver improved prescription pricing at more than 2,200 Kroger family pharmacy locations nationwide.

GoodRx, the leading destination for prescription savings in the U.S., today announced that Publix has joined the GoodRx Gold network. Members now have access to prescription savings of up to 90%1 at more than 1,200 Publix pharmacy locations across the Southeast.

GoodRx, the leading destination for prescription savings in the U.S., today announced it is offering 30 of the most common heart health medications for under $30 at more than 70,000 pharmacies nationwide.1 Cardiovascular disease is one of the most prominent conditions facing Americans, affecting nearly half of all U.S. adults. That’s why GoodRx is making it easier for all individuals, regardless of insurance status, to access savings on both generic and brand-name medications that mitigate the risk and impact of cardiovascular conditions such as coronary artery disease, high cholesterol, hypertension, and more.

GoodRx (NASDAQGDRX), the leading destination for prescription savings, today shared a report looking at the company’s impact on social welfare as a result of helping millions of people access affordable medications. “The GoodRx Effect: How GoodRx is Changing the Economics of Healthcare” shows that by saving people money and improving medication adherence, GoodRx positively impacts health outcomes and significantly reduces costs within the healthcare system – including saving the healthcare system an estimated $5 billion to date.

GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the election of Kelly J. Kennedy to its Board of Directors. Kennedy will serve as a member of the Board’s audit committee and fill the seat left vacant by Jacqueline Kosecoff earlier this year.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, today announced it is working with Sanofi NASDAQ: SNYNASDAQSNY)

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, and Navitus Health Solutions, LLC, a pass-through pharmacy benefit manager (PBM) committed to removing cost from the drug supply chain, today announced the launch of Savings Connect. This program, when elected by clients, provides members with automatic access to GoodRx prices on generic drugs in a seamless experience at the pharmacy counter. Consumers no longer have to proactively review and choose between using their insurance or a discounted price available through GoodRx. Both prices are compared behind the scenes and the lowest one is delivered directly to the consumer.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, today announced it is offering new savings on antivirals, medications and vaccines for the upcoming cold and flu season. Last flu season (October 1, 2022 through April 30, 2023), the CDC estimates that influenza was associated with more than 27 million illnesses, 300,000 hospitalizations, and 19,000 deaths, showing the importance of Americans taking preventative measures to protect themselves from the virus and understand the treatment options available if they get sick. With these significant savings, Americans can find affordable ways to prevent or treat seasonal illnesses, regardless of insurance status.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, and MedImpact, the independent pharmacy benefit manager (PBM) and health solutions company, today announced a new savings solution designed to integrate GoodRx’s prescription pricing in a seamless experience at the pharmacy counter. Now, when an eligible MedImpact member fills a prescription for a generic medication, it will automatically compare their benefit and the GoodRx price and then deliver the lowest one. The amount paid will be applied to the member’s deductible.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, today announced a new initiative at Walgreens to reduce prices on nearly 200 prescription medications by an average of 40%, with even greater savings available for select medications. Consumers can now purchase many popular prescriptions at Walgreens for less than $15 for a 30-day fill, without any deductibles, restrictions, paperwork, approvals or quantity limitations.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, today announced the launch of real-time benefit check (RTBC) in Provider Mode. Developed in collaboration with AssistRx, the advanced therapy initiation and patient solutions provider, real-time benefit check gives healthcare professionals (HCPs) immediate access to eligible patients’ insurance coverage and greater visibility into the cost of brand and specialty drug prescriptions at the point of prescribing. Over 550,000 HCPs have used Provider Mode to date, and GoodRx’s comprehensive price comparison features, which now include real-time benefit check, enable them to see the cost of a prescription with insurance, with GoodRx, or with a manufacturer’s savings program.

GoodRx is a leading resource for people with diabetes to find prescription savings and information, having helped almost 2.5 million Americans save more than $500 million on diabetes treatments to date. By offering invaluable access to affordable diabetes medicines and glucose monitors, accurate and digestible information about treatment options, and thorough research on diabetes and insulin prices, GoodRx is making it easier for people to afford their medications and adhere to their treatment plans.

GoodRx (NASDAQGDRX), a leading resource for healthcare savings and information, today announced Medicine Cabinet, a comprehensive solution designed to help consumers seamlessly manage their medications. Medicine Cabinet gives people easy-to-use tools to keep track of their prescriptions, get refill and daily pill reminders, find low prices, and earn rewards for staying on track. By making prescription management easier, smarter and more relevant, Medicine Cabinet will better enable consumers to stay adherent to their treatment plans and manage their overall healthcare costs.

GoodRx (Nasdaq: GDRX), a leading resource for healthcare savings and information, today announced the appointment of Dorothy Gemmell as Chief Commercial Officer, effective July 3, 2023. Gemmell will work closely with Aaron Crittenden, newly appointed Chief Revenue Officer, and together they will lead the company’s Pharma Manufacturer Solutions business, which provides solutions for pharmaceutical and medical device companies.

At GoodRx, protecting our users’ privacy is one of our most important priorities. We are thoughtful and disciplined about what information we gather and how and why we use it.

GoodRx (NASDAQGDRX), a leading consumer-focused digital healthcare platform, today released a new report that indicates that policies that expand pharmacists’ prescribing and dispensing authority greatly improve access to critical medications. The average person sees their pharmacists nearly 12 times more frequently than their HCPs, creating an enormous opportunity to bridge current gaps in the healthcare system.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the launch of Provider Mode, a new experience that is built specifically for healthcare providers (HCPs) to help them find affordable solutions for the medications they prescribe. Built by GoodRx’s own team of medical professionals along with external healthcare provider focus groups, Provider Mode offers customized tools designed to help HCPs and office staff support patients throughout their healthcare journey.

GoodRx (NASDAQGDRX), a leading consumer-focused digital healthcare platform, today announced a collaboration with Biogen NASDAQ: BIIBNASDAQBIIB)

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it is offering free online healthcare provider visits to Florida residents impacted by Hurricane Ian. Now through October 17, Florida residents can visit http://goodrx.com/fl and use the code FL-CARE-100 to be seen by a licensed medical provider on GoodRx Care for a variety of conditions not requiring lab work.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it is offering free online healthcare provider visits to Kentucky residents impacted by local flooding. Now through the end of August, Kentuckians can visit goodrx.com/ky and use the code KY-CARE-100 to be seen by a licensed medical provider on GoodRx Care for a variety of conditions not requiring lab work.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced a strategic relationship with RxVantage that will enable healthcare providers to connect with manufacturers on the GoodRx platform. Over 700,000 prescribers have used GoodRx since June 2021, and GoodRx expects the new integration from this strategic relationship will enable them to easily connect with pharma representatives to ask questions about new therapies, indications, side effects, patient assistance programs, and clinical resources. By streamlining access to the valuable educational resources and expertise that pharmaceutical companies offer, the expected integration will be able to better serve already time-constrained providers and help them provide better resources to their patients.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it has made key leadership appointments to support the company’s scaling business and accelerate innovation to bring more affordable and convenient healthcare to consumers across the country.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced a new effort with AssistRx to bring broader awareness and access to branded and specialty medication therapy initiation. GoodRx will leverage its large provider reach to drive attention to AssistRx’s iAssist platform, which gives providers immediate access to a patient’s coverage, improved price transparency and the right prior authorization information.

GoodRx (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced the completion of its previously announced acquisition of vitaCare for $150 million in cash, with an additional $7 million of consideration contingent payment upon vitaCare’s financial performance through 2023. VitaCare is a pharmacy services platform that expands GoodRx’s offering to pharmaceutical manufacturers while helping to improve patient access and adherence to affordable brand drugs. The acquisition will enable GoodRx to help more patients receive their prescriptions in an efficient, affordable, and transparent manner, and stay on their prescribed therapies as long as appropriate. In addition, the acquisition is expected to further strengthen our rapidly growing Pharma Manufacturer Solutions offerings which span medication awareness, access, and adherence with unique capabilities.

GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced it will release its first quarter 2022 financial results after U.S. markets close on Monday, May 9, 2022. GoodRx management will hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company’s business outlook. Prior to the call, GoodRx will issue a press release containing a link to a shareholder letter and the Company’s first quarter 2022 financial results on its investor relations website at https://investors.goodrx.com.

GoodRx, Inc. (NASDAQGDRX), America’s digital resource for healthcare, and Fetch Rewards, America’s No. 1 rewards app, today announced that GoodRx has been named the exclusive prescription savings provider for Fetch Rewards. Fetch Rewards’ more than 10 million active shoppers can now find GoodRx prescription savings directly in the Fetch app, allowing them to seamlessly access discounts on medications at more than 70,000 pharmacies nationwide. By using GoodRx through Fetch Rewards, users will receive rewards points in the Fetch app that can be redeemed for free gift cards to hundreds of popular retailers and restaurants, or donated to over 20 different charitable organizations.

GoodRx (Nasdaq: GDRX), America’s digital resource for healthcare, today launched GoodRx Health to provide research-based answers to vital health questions. Unlike other consumer health destinations, GoodRx Health takes a new approach to health information with concise, actionable knowledge delivered via GoodRx Answers, Health Wizard tools for navigating tough choices, and thousands of award-winning Explainer videos on today’s crucial health concerns.

GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its first quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com.

GoodRx Holdings Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced that executives from the Company will be presenting at the following virtual investor conferences:

GoodRx (Nasdaq: GDRX), America’s leading resource for healthcare savings, today announced an integrated offering with global biopharmaceutical company Sanofi (Nasdaq: SNY) to streamline patient access to Sanofi discounts. Commercially insured and uninsured patients can now find, apply for, and claim Sanofi manufacturer discounts directly on the GoodRx platform. This integration makes it easier for the millions of people living with diabetes to access insulin, with the potential to save Americans up to $260 million or more on first fill costs in 2021, based on internal estimates. The ability to determine patient eligibility and receive Sanofi manufacturer coupons - that can be used at the pharmacy - directly on the GoodRx platform represents new functionality that will make brand-drug savings more accessible to GoodRx users who qualify.